Skip to main content
Caplight Logo









Juniper Biomedical

Juniper Biomedical

Private
Worcester, MassachusettsHealthcare & Life Scienceshttps://www.juniperbiomedical.com/

Last Round

Grant

Dec 10, 2025

Total Funding Raised

$4.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Juniper Biomedical is a medical device company that develops implantable neuromodulation systems to treat pelvic health conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neuromodulationimplantable medical devicepelvic healthnerve stimulationbioelectronic medicineurinary incontinencebowel incontinencepelvic painminimally invasivemicro-neuromodulatormedtechimplantable techperipheral nerve stimulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Juniper Biomedical Comparables

Compare Juniper Biomedical with similar companies based on industry and business-model similarity.

Juniper Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuspera Medical
83%
BlueWind Medical
83%
Amber Therapeutics
80%

Juniper Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 10, 2025
SeedApr 2, 2024
GrantApr 2, 2024

Key People

Founding team and executive leadership

Mario Romero-Ortega

Co-Founder and Chief Scientific Officer

Founding Team

David N Constantine

Co-Founder & CEO

Founding Team

Gregory Martin

Chief Technology Officer

Executive Team

Jayme Coates

Chief Operating Officer

Executive Team

Juniper Biomedical Investors

Notable investors and investment history

Juniper Biomedical investors
InvestorRounds
NIH RADxGrant
Beacon AngelsSeed
Hub Angels Investment GroupSeed
Atma CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Monthly visitors grew 40% MoM.

  • Jan 20, 2026

    Monthly visitors grew 95% MoM.

Juniper Biomedical Filings

Explore SEC and related filing metadata, where available.

Juniper Biomedical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Juniper Biomedical's valuation, stock price, and market status.

Is Juniper Biomedical a public or private company?

Juniper Biomedical is a private company.

What is the current stock price of Juniper Biomedical?

Juniper Biomedical is a private company with no public stock price. No recent secondary market data is available.

How much is Juniper Biomedical worth (valuation)?

Valuation information for Juniper Biomedical is not publicly available.

Can I buy Juniper Biomedical stock?

Juniper Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Juniper Biomedical's last funding round?

Juniper Biomedical's most recent funding round was Grant on December 10, 2025.

Who are the main investors in Juniper Biomedical?

Key investors in Juniper Biomedical include NIH RADx, Beacon Angels, Hub Angels Investment Group, Atma Capital.

Will Juniper Biomedical IPO soon?

No public IPO plans have been announced for Juniper Biomedical.

How can I track Juniper Biomedical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Juniper Biomedical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWorcester, Massachusetts
Employee Range8
Year Founded2019
Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?